Elekta Unity, World's First High-Field MR-Linac, Receives CE Mark
STOCKHOLM, June 18, 2018 -- (Healthcare Sales & Marketing Network) -- New radiation therapy system will now be implemented clinically in Europe, ushering in a transformation in precision and personalized cancer treatment Elekta (EKTA-B.ST) earlier toda... Devices, Oncology, Radiology, Regulatory Elekta, Elekta Unity, magnetic resonance, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 18, 2018 Category: Pharmaceuticals Source Type: news

‘Supercharged’ Immunotherapy Could Target Mesothelioma Cell Protein
Standard mesothelioma treatment options include surgery, radiation therapy, chemotherapy and multimodal therapy. These standard therapies do not offer a cure for people with mesothelioma, and that’s why scientists continue searching for better ways to treat the disease. Researchers at the Scripps Research Institute in Jupiter, Florida, have created a precision medicine approach that targets a protein on the surface of cancer cells to kill tumors. Although the drug was not specifically designed for mesothelioma patients, it may offer a more effective way to manage the disease in the future. The treatment is a type of...
Source: Asbestos and Mesothelioma News - June 18, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

CDH Beats Varian in Bid for Embattled Sirtex
Money talked and Sirtex Medical listened. The New South Wales, Australia-based medical device company that provides a targeted internal radiation therapy for certain liver cancers, said its board decided that the competing bid from CDH Investments was superior to the earlier bid it received from Varian. In January, Palo Alto, CA-based Varian offered to pay about $1.3 billion (A$28 a share) to acquire Sirtex, and the two companies entered into an agreement, which Sirtex shareholders were expected to approve on May 7. That was until CDH, a major alternative asset management firm based in Beijing, Chi...
Source: MDDI - June 14, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

American Society for Radiation Oncology (ASTRO) 60th Annual Meeting in San Antonio, October 21-24
(American Society for Radiation Oncology) The American Society for Radiation Oncology (ASTRO) will host its 60th Annual Meeting at the Henry B. Gonzalez Convention Center in San Antonio, October 18-24, 2018. The meeting will feature updates from clinical trials and cancer research involving radiation therapy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 14, 2018 Category: International Medicine & Public Health Source Type: news

New radiation therapy technique aims to preserve sexual function
(UT Southwestern Medical Center) A multicenter clinical trial being led by UT Southwestern physicians is testing a technique for sparing nerve bundles and arteries involved in sexual function to preserve potency in patients getting radiation therapy for prostate cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 12, 2018 Category: Cancer & Oncology Source Type: news

PSA'Bounce' Probably Not an Adverse Effect of Radiation PSA'Bounce' Probably Not an Adverse Effect of Radiation
Dr Chodak discusses significant findings on the implications of PSA bounce after external beam radiation therapy.Medscape Urology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 6, 2018 Category: Consumer Health News Tags: Urology Commentary Source Type: news

Irradiating chest lymph nodes in patients with early stage breast cancer improves survival without increasing side effects
(European Organisation for Research and Treatment of Cancer) Giving radiation therapy to the lymph nodes located behind the breast bone and above the collar bone to patients with early stage breast cancer improves overall survival without increasing side effects, and this effect continues for 15 years, researchers have found. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 1, 2018 Category: International Medicine & Public Health Source Type: news

Mother battled 17 brain tumours to defy doctors who said she was terminal in 2015
Sue Nicklan, 54, a nurse from Chelford, Cheshire, battled 17 brain tumours with Gamma Knife radiation therapy after she had already fought off breast, lung and liver cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - May 25, 2018 Category: Consumer Health News Source Type: news

Few Radiotherapy Trials, Despite Wide Use Few Radiotherapy Trials, Despite Wide Use
The limited number of radiation therapy trials and lack of funding for such studies is"concerning," given that radiation is a cornerstone of cancer management worldwide, researchers in China say.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 22, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Blue Earth & #039;s Test Can Play Significant Role in Prostate Cancer Treatment
Topline results seem to give support to Blue Earth Diagnostics’ test to help impact treatment decisions for patients. The Burlington, MA-based company presented results from the LOCATE investigational trial at the American Urology Association’s annual meeting. LOCATE is a prospective, multi-center, open label study conducted at 15 sites in the U.S. The study’s primary endpoint measured the percentage of men with suspected biochemical recurrence of prostate cancer following initial prior therapy whose treatment plan was changed following Blue Earth Diagnostics’ 18F fluciclovine PET/CT scan. The ...
Source: MDDI - May 22, 2018 Category: Medical Devices Authors: Omar Ford Tags: Imaging Source Type: news

Compound in citrus oil could reduce dry mouth in head, neck cancer patients
(Stanford Medicine) A compound found in citrus oils could help alleviate dry mouth caused by radiation therapy in head and neck cancer patients, according to a new study by researchers at the Stanford University School of Medicine. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 21, 2018 Category: Cancer & Oncology Source Type: news

I Took the First FDA-Approved Migraine Prevention Treatment. It Transformed My Life
On Thursday, the Food and Drug Administration approved the first drug designed to prevent chronic migraine headaches. Aimovig, made by Amgen and Novartis, is a monthly, self-administered injection that blocks a molecule involved in migraine attacks. Over the course of three clinical trials, the drug was successful at reducing the frequency of migraines for chronic sufferers. It is expected to be available in as soon as a week and will cost $575 per month, though out-of-pocket costs will vary depending on insurance. This is the story of Susan Giordano, 58, whose chronic migraines have nearly ceased after taking a monthly s...
Source: TIME: Health - May 18, 2018 Category: Consumer Health News Authors: Susan Giordano Tags: Uncategorized healthytime medicine onetime Source Type: news

Varian inks Brazilian training, education deal
Varian Medical (NYSE:VAR) said today it inked a software technology training and education cooperation agreement with the Brazil Ministry of Health and seven universities and science and tech institutes in the country. The Palo Alto, Calif.-based medical device maker said the agreement is part of its strategy of partnering with the Ministry of Health to increase quality and access to radiotherapy treatments in Brazil and across Latin America. Varian said that the list of participating institutions includes the Universidade Federal de São Paulo, Universidade Federal de Pernambuco, Instituto Nacional de Telecomun...
Source: Mass Device - May 17, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Oncology Varian Medical Systems Source Type: news

Stunned scientists find BLUEBERRIES are better at destroying cancer cells than conventional radiation therapy alone
(Natural News) Cervical cancer strikes close to 13,000 women each year, claiming over 4,200 lives. Traditional treatment options include surgery to remove the affected tissue, radiation therapy using high energy x-rays to destroy cancer cells, chemotherapy drugs to destroy the affected cells (although healthy cells are killed too), or a combination thereof. However, these treatments... (Source: NaturalNews.com)
Source: NaturalNews.com - May 15, 2018 Category: Consumer Health News Source Type: news

Chemo, radiation, therapy — and don't forget exercise
The prescription pad is increasingly getting a workout as exercise is being prescribed for a host of conditions, from depression to diabetes to cardiovascular disease. Now a group of Australian oncologists want to prescribe exercise for all cancer patients, alongside surgery, chemotherapy and radiation. (Source: CBC | Health)
Source: CBC | Health - May 15, 2018 Category: Consumer Health News Tags: News/Health Source Type: news

Cleveland Clinic receives $2 million grant to study cancer genetics and radiation effectiveness
The objective for this award is to identify new genetic markers calibrated on the basis of radiation therapy effectiveness and new drug-radiation therapy strategies that more precisely and effectively target the most resistant lung tumors to radiation. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 15, 2018 Category: Cancer & Oncology Source Type: news

ViewRay posts Q1 revenue increase
Image-guided radiation therapy developer ViewRay reported a boost in first-quarter...Read more on AuntMinnie.comRelated Reading: ViewRay wins Fla. MRIdian Linac installation ViewRay sells milestone linacs to Rad Technology ViewRay lands Japanese regulatory approval for MRI linac ViewRay secures $59M in financing ViewRay announces changes to board of directors (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 11, 2018 Category: Radiology Source Type: news

An AI oncologist to help cancer patients worldwide
(University of Texas at Austin, Texas Advanced Computing Center) Before performing radiation therapy, oncologists review medical images to identify tumors and surrounding tissue, a process known as contouring. Researchers from MD Anderson Cancer Center developed a new method for automating the contouring of high-risk clinical target volumes using artificial intelligence and supercomputers. They found the predicted contours could be implemented clinically, with only minor or no changes. Results appear in the June 2018 issue of the International Journal of Radiation Oncology*Biology*Physics. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 9, 2018 Category: Cancer & Oncology Source Type: news

Researchers link brain tumor treatment to GBCA deposition
Could the treatment of brain tumors with radiation therapy contribute to the...Read more on AuntMinnie.comRelated Reading: Evidence mounts: Use macrocyclic GBCAs in pediatric MRI Pediatric radiology abandons linear gadolinium contrast No signal intensity for pediatric patients with macrocyclic GBCA Switch to macrocyclic GBCAs reduces brain signals Study finds gadolinium hot spots, but no clinical effects (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 8, 2018 Category: Radiology Source Type: news

Sensus Healthcare Appoints Dr. Isabelle Raymond as Vice President, Clinical Development
New Executive Leader Brings Extensive Clinical Research, Medical Marketing and Product Launch Experience to the Company BOCA RATON, Fla., May 8, 2018 -- (Healthcare Sales & Marketing Network) -- Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device ... Devices, Oncology, Dermatology, Personnel Sensus Healthcare, superficial radiation therapy, skin cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 8, 2018 Category: Pharmaceuticals Source Type: news

For patients with esophageal cancer, status of lymph nodes after preoperative therapy determines survival
(American Association for Thoracic Surgery) The status of lymph nodes rather than the status of the primary tumor following preoperative neoadjuvant chemotherapy or chemoradiation therapy is the most important factor that determines whether patients with locally advanced esophageal cancer will survive. The study presented at the AATS 98th Annual Meeting indicates that while preoperative chemotherapy and radiation therapy improve survival of patients with esophageal cancer, patients with malignant lymph nodes following therapy were less likely to survive than patients with no cancer in the lymph nodes. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 1, 2018 Category: Cancer & Oncology Source Type: news

FDA clears Mobius Imaging ’ s Airo Mobile CT imager for pediatric use
Mobius Imaging said yesterday it won FDA 510(k) clearance for its Airo Mobile CT imaging system designed for pediatric applications. The Shirley, Mass.-based company said it previously won FDA 510(k) clearance in 2013 for non-pediatric imaging, and is designed for use in applications supporting brachytherapy, radiation therapy and surgical imaging. The new clearance is an important milestone for the company, Mobius said, expanding the use of the Airo CT system into new segments and applications. “There is an unmet need in being able to provide safe and reliable CT imaging for pediatric patients during various clinica...
Source: Mass Device - April 27, 2018 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Food & Drug Administration (FDA) Imaging Regulatory/Compliance mobiusimaging Source Type: news

Varian Medical Q2 beats The Street
Shares in Varian Medical (NYSE:VAR) have risen slightly today in after hours trading after the medical device maker posted fiscal year 2018 second quarter earnings that beat The Street and saw profits and sales grow. The Palo Alto, Calif.-based company posted profits of $73.2 million, or 79¢ per share, on sales of $729.9 million for the three months ended March 30, for bottom-line growth of 5.3% on sales growth of 10.1% compared with the same period last year. After adjusting to exclude one-time items, earnings per share were 1.15¢, ahead of the $1.04 consensus on The Street, where analysts were looking for ...
Source: Mass Device - April 25, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News MassDevice Earnings Roundup Wall Street Beat Varian Medical Systems Source Type: news

Sensus Healthcare inks multiple distro deals, launches global expansion project
Superficial radiation therapy device developer Sensus Healthcare (NSDQ:SRTSU) today released plans for a global expansion, including new distribution agreements in China, Germany, Mexico, Cuba and Costa Rica. Sensus makes low-energy photon X-ray systems for treating non-melanoma skin cancers, including basal cell and squamous cell carcinomas, and keloids. The Boca Raton, Fla.-based company refers to the technology as superficial radiation therapy, and claims that the tech has been sued to “effectively and safely treat oncological and non-oncological skin conditions.” “Following our new partnersh...
Source: Mass Device - April 19, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Distribution Oncology Sensus Healthcare LLC Source Type: news

Varian releases Halcyon updates
Varian Medical Systems has released updates to its Halcyon radiation therapy...Read more on AuntMinnie.comRelated Reading: Varian releases new version of Velocity Brainlab, Varian team up on product integrations Varian bid for Sirtex clears regulatory hurdle Varian touts proton therapy educational milestone Varian acquires decision-support firm (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 19, 2018 Category: Radiology Source Type: news

Philips inks collab software integration deal with Sun Nuclear
Royal Philips (NYSE:PHG) said today it inked a collaborative deal with Sun Nuclear to integrate its PlanIQ software into Philips’ Pinnacle 16.2 auto-planning software. Amsterdam-based Philips said that the PlanIQ software is designed to provide clinicians with patient-specific goals and treatment plans for oncology treatments, adding that integration with its Pinnacle auto-planning software will improve the efficiency of creating personalized treatment plans. “Today’s radiation oncology treatment planning processes are still fragmented, labor-intensive and time-consuming, potentially producing i...
Source: Mass Device - April 19, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Oncology royalphilips sunnuclear Source Type: news

Pleurectomy and Decortication the ‘ Way to Go ’ for Mesothelioma
Dr. Pietro Bertoglio and his colleagues at the University Hospital of Pisa stopped performing the aggressive extrapleural pneumonectomy (EPP) surgery for mesothelioma more than a decade ago. They believe it’s long overdue for everyone else to do the same and instead use the less-debilitating pleurectomy/decortication (P/D) procedure. The Journal of Thoracic and Cardiovascular Surgery recently published the University Hospital of Pisa’s 10-year experience using P/D and hyperthermic intrathoracic chemotherapy (HITHOC). Two editorial commentaries from thoracic surgeons in the U.S. accompanied the study from Italy,...
Source: Asbestos and Mesothelioma News - April 16, 2018 Category: Environmental Health Authors: Daniel King Source Type: news

Is whole-brain radiation still best for brain metastases from small-cell lung cancer?
(University of Colorado Anschutz Medical Campus) University of Colorado Cancer Center study compares outcomes of 5,752 small-cell lung cancer patients who received whole-brain radiation therapy (WBRT) with those of 200 patients who received stereotactic radiosurgery (SRS), finding that the median overall survival was actually longer with SRS (10.8 months with SRS versus 7.1 months with WBRT). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 16, 2018 Category: International Medicine & Public Health Source Type: news

Selective internal radiation therapy (SIRT) fails to extend survival in the SORAMIC study palliative cohort
(European Association for the Study of the Liver) ILC 2018: The addition of SIRT to sorafenib in patients with advanced hepatocellular carcinoma was associated with no overall survival benefits compared with sorafenib alone, but may offer benefits in some subgroups of patients (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 13, 2018 Category: Cancer & Oncology Source Type: news

Cancer radiation "treatment" claims proven FALSE: New study proves higher doses do not improve survival in prostate cancer patients
(Natural News) Radiation therapy isn’t anybody’s idea of a good time, but each year, thousands of people undergo the treatment in hopes of curing their cancer. If it can save your life, the side effects are worth it, right? Unfortunately, there’s one small problem with this line of reasoning: Radiation does not always improve a... (Source: NaturalNews.com)
Source: NaturalNews.com - April 10, 2018 Category: Consumer Health News Source Type: news

Varian Medical releases new Velocity cancer imaging software
Varian Medical (NYSE:VAR) said today it launched an FDA-cleared version of its Velocity cancer imaging software, including a new Rapidsphere module. The newly launched Velocity 4.0’s Rapidsphere module is designed for Y90 selective internal radiation therapy dosimetry analysis and provides improved information on tumor responses and normal-tissue toxicity for patients undergoing SIRT, the Palo Alto, Calif.-based company said. The Velocity 4.0 software includes the company’s Velocity M3i multi-modality motion imaging component, the Velocity Aria sync component and the Velocity tumor & dose tracking comp...
Source: Mass Device - April 9, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Imaging Oncology Software / IT Varian Medical Systems Source Type: news

Varian releases new version of Velocity
Varian Medical Systems has released a new version of its Velocity cancer imaging...Read more on AuntMinnie.comRelated Reading: Brainlab, Varian team up on product integrations Varian bid for Sirtex clears regulatory hurdle Varian touts proton therapy educational milestone Varian acquires decision-support firm India clears Varian's Halcyon radiation therapy system (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 9, 2018 Category: Radiology Source Type: news

Elekta Strengthens Presence in Mexico With Government Tender for Radiation Therapy Technology
Elekta further invests in Mexico with new offices and fortified workforce MEXICO, April 9, 2018 -- (Healthcare Sales & Marketing Network) -- Elekta (EKTA-B.ST) announced today that it has won a government tender to supply Instituto Mexicano del Seguro ... Devices, Oncology Elekta, Elekta Synergy, Elekta Infinity, linear accelerator, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 9, 2018 Category: Pharmaceuticals Source Type: news

Narayana Health unveils latest cancer radiation therapy technology Versa HD
Developed by Swedish company Elekta, 'Versa HD' as it is known, has the versatility to deliver conventional radiotherapy and a variety of indications and treatment techniques. (Source: The Economic Times)
Source: The Economic Times - April 8, 2018 Category: Consumer Health News Source Type: news

ASTRO updates guideline for lung cancer radiation therapy
The American Society for Radiation Oncology (ASTRO) has revised its radiation...Read more on AuntMinnie.comRelated Reading: ASRT backs ASTRO safety, quality initiative ASTRO releases new breast radiation therapy guideline ASTRO commends payment freeze for radiation treatment ASTRO chair set to testify on Medicare payment reform ASTRO: Short radiation course safe for breast cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 5, 2018 Category: Radiology Source Type: news

Updated ASTRO guideline for palliative lung RT recommends concurrent chemo for some stage III pts
(American Society for Radiation Oncology) The American Society for Radiation Oncology (ASTRO) today issued an update to its clinical guideline for the use of palliative-intent radiation therapy for patients with incurable non-small cell lung cancer (NSCLC). Reflecting new evidence from randomized clinical trials, the guideline now recommends the addition of concurrent chemotherapy to radiation therapy for certain patients with incurable stage III NSCLC, including those who are able to tolerate chemotherapy and have a life expectancy longer than three months. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 4, 2018 Category: Cancer & Oncology Source Type: news

Ionizing radiation found to soften tumor cell microenvironment
(American Institute of Physics) Researchers from Vanderbilt aim to unlock how irradiation -- part of radiation therapy in cancer treatment -- might alter the mechanical properties of the microenvironment. The team demonstrated that ionizing radiation can reduce the stiffness of both the extracellular matrix of an extracted tumor and an isolated matrix of collagen fibers. Appearing this week in APL Bioengineering, the results pave the way for irradiation to be used to create matrices with tailored properties. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 3, 2018 Category: Cancer & Oncology Source Type: news

Proton RT for Prostate Cancer Has Reduced Toxicity, Higher Cost vs Other RT Options
Proton radiation therapy offers some reduced toxicity over IMRT in patients under the age of 65 with prostate cancer, but its cost is nearly double. (Source: CancerNetwork)
Source: CancerNetwork - March 26, 2018 Category: Cancer & Oncology Authors: Dave Levitan Tags: Genitourinary Cancers News Prostate Cancer Source Type: news

New Targeted Therapy May Benefit Mesothelioma Patients
For newly diagnosed mesothelioma patients, standard treatment options include surgery, radiation therapy, chemotherapy and multimodal therapy, which combines these options in various ways. However, more physicians are adding precision medicine to the mix, including targeted therapies such as immunotherapy or drugs aimed at a specific genetic mutation in a tumor. Clinical trials have shown a new drug called AZD5363 attacks a gene that is mutated in some mesothelioma tumors. The drug was not designed for mesothelioma patients, but it may offer another mesothelioma treatment avenue in the future. Limited Options Inspire New T...
Source: Asbestos and Mesothelioma News - March 23, 2018 Category: Environmental Health Authors: Daniel King Source Type: news

Medical students get little training in radiation oncology
Medical school students receive little formal instruction in radiation oncology,...Read more on AuntMinnie.comRelated Reading: ASRT backs ASTRO safety, quality initiative ASTRO releases new breast radiation therapy guideline Siris signs on UCSF for radiation oncology software ASTRO commends payment freeze for radiation treatment Microbubbles improve breast cancer radiation therapy (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 23, 2018 Category: Radiology Source Type: news

ViewRay wins Japanese approval for MRIdian Linac system
ViewRay (NSDQ:VRAY) said today it won Japanese Ministry of Health, Labor and Welfare Shonin approval for its MRIdian Linac linear accelerator system. The newly cleared MRIdian Linac device replaces the cobalt it utilized with linear accelerator technology, the Cleveland, Ohio-based company said. The company won FDA approval for the device last February. ViewRay touted the MRIdian as the first and only MRI-guided radiation therapy system to receive Japanese Shonin approval. The company is represented by Itochu corporation in Japan, which it claims is one of the three largest general trading companies in the c...
Source: Mass Device - March 15, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Imaging Regulatory/Compliance ViewRay Inc. Source Type: news

ViewRay lands Japanese regulatory approval for MRI linac
Image-guided radiation therapy developer ViewRay has secured approval from...Read more on AuntMinnie.comRelated Reading: ViewRay secures $59M in financing ViewRay announces changes to board of directors ViewRay touts pancreatic cancer study results ViewRay launches multicenter trial for pancreatic cancer ViewRay sees Q2 sales grow, net loss narrows (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 15, 2018 Category: Radiology Source Type: news

Improved capture of cancer cells could aid in disease tracking
(UNC Lineberger Comprehensive Cancer Center) In the journal Clinical Cancer Research, researchers reported that by forcing cancer cells to slow down and developing stronger molecular traps for them, they could identify large numbers of the cells in cancer patients undergoing radiation therapy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 15, 2018 Category: International Medicine & Public Health Source Type: news

Higher doses of radiation don't improve survival in prostate cancer
(Washington University School of Medicine) A new study shows that higher doses of radiation do not improve survival for many patients with prostate cancer, compared with the standard radiation treatment. The analysis, which included 104 radiation therapy oncology groups across North America, was led by researchers at Washington University School of Medicine in St. Louis. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 15, 2018 Category: Cancer & Oncology Source Type: news

ASRT backs ASTRO safety, quality initiative
The American Society of Radiologic Technologists (ASRT) has provided financial...Read more on AuntMinnie.comRelated Reading: ASTRO releases new breast radiation therapy guideline ASRT elects board of directors for 2018-2019 ASRT: Radiography program enrollment rises ASTRO commends payment freeze for radiation treatment ASRT selects international speaker award recipients ASTRO chair set to testify on Medicare payment reform (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 14, 2018 Category: Radiology Source Type: news

ASTRO releases new breast radiation therapy guideline
The American Society for Radiation Oncology (ASTRO) has issued a new clinical...Read more on AuntMinnie.comRelated Reading: ASTRO commends payment freeze for radiation treatment ASTRO chair set to testify on Medicare payment reform ASTRO: Short radiation course safe for breast cancer ASTRO: Breast radiation 'less scary' than expected ASTRO awards $275K to researchers (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 12, 2018 Category: Radiology Source Type: news

ASTRO issues clinical guideline for whole breast radiation therapy
(American Society for Radiation Oncology) The American Society for Radiation Oncology (ASTRO) today issued a new clinical guideline for the use of whole breast radiation therapy for breast cancer that expands the population of patients recommended to receive accelerated treatment known as hypofractionated therapy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 12, 2018 Category: Cancer & Oncology Source Type: news

Anti –Oral Mucositis Drug Granted Breakthrough Status
The FDA has granted Breakthrough Therapy and Fast Track designation to GC4419, for reduction of severe oral mucositis caused by radiation therapy. (Source: CancerNetwork)
Source: CancerNetwork - March 9, 2018 Category: Cancer & Oncology Authors: Leah Lawrence Tags: FDA Approval News Palliative and Supportive Care Source Type: news

Varian touts proton therapy educational milestone
Varian Medical Systems is highlighting an educational milestone at the Maryland...Read more on AuntMinnie.comRelated Reading: Varian acquires decision-support firm India clears Varian's Halcyon radiation therapy system Varian acquires Mobius Medical Varian inks deal to acquire Sirtex for $1.3B Varian posts double-digit Q1 gain (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 5, 2018 Category: Radiology Source Type: news

Galera's new drug candidate granted breakthrough therapy status
The experimental therapy targets a painful side effect of radiation therapy. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - March 1, 2018 Category: American Health Authors: John George Source Type: news